Inovio: EU Grants Orphan Drug Designation For INO-3107
WASHINGTON (dpa-AFX) - Inovio (INO) said that the European Commission granted orphan drug designation for INO-3107, the company's product candidate for the treatment of Recurrent Respiratory Papillomatosis
United States Gewinn Nur European Committee For Orphan Medicinal Products More Such Health News European Union European Commission
Source: finanznachrichten.de